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Transseptal Left Heart Catheterization
Old Techniques for New Procedures
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Transseptal (TS) catheterization was introduced in 1959 as a strategy to directly measure left atrial (LA) pres-
sure. Despite acceptable feasibility and safety, TS catheterization has been replaced by indirect measurements
of LA pressure using the Swan-Ganz catheter. Today, TS puncture is rarely performed for diagnostic purposes but
continues to be performed for procedures such as balloon mitral valvuloplasty, antegrade balloon aortic valvulo-
plasty, and ablation of arrhythmias in the LA. Thus, the “art” of TS puncture has been lost, except in centers that
perform these procedures with regularity. Recently, there has been a renewed interest in the TS technique be-
cause of emerging therapeutic procedures for structural heart disease and atrial fibrillation ablation. Invasive
cardiologists will have to refamiliarize themselves with the TS technique, newer TS devices, and advanced ultra-
sound imaging for guidance of the procedure. (J Am Coll Cardiol 2008;51:2116–22) © 2008 by the American
College of Cardiology Foundation
























oeasurement of left atrial (LA) pressure is important in the
valuation of heart disease. Various direct methods, such as
ransbronchial, supraclavicular (1), and transseptal (TS)
uncture (2–4), were developed in the 1950s to measure LA
ressure. Despite acceptable feasibility and safety (1,2,5),
hese methods were replaced by indirect measurements of
A pressure with a Swan-Ganz catheter. Right heart
atheterization with a balloon wedge catheter replaced TS
eft heart catheterization not only because of ease and safety,
ut because many hemodynamic parameters could be mea-
ured with a single catheter. Today, TS catheterization is
arely performed for diagnostic purposes unless the wedge
ressure reading is in question or retrograde access to the
eft ventricle is not possible. Thus, the “art” of TS puncture
as been lost by invasive cardiologists, except in centers that
erform balloon mitral valvuloplasty and LA arrhythmia
blation with regularity.
With the introduction of new procedures for percutane-
us structural heart disease therapy (6–8) and atrial fibril-
ation ablation (9) in the last 5 years, TS catheterization is
ncreasingly necessary. This review focuses on the current
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008, accepted January 24, 2008.tate of TS catheterization, with emphasis on updated
echniques and emerging indications.
S Technique
urrent TS technique has changed very little since the
nitial reports in 1959 (3,4). In brief, a needle is inserted into
catheter that is in contact with the right atrial (RA)
eptum at the level of the fossa ovalis. The needle is then
dvanced, puncturing the atrial septum and allowing access
o the LA. The key to a successful procedure is a thorough
nderstanding of the anatomy of the fossa ovalis and the
urrounding landmarks.
natomy of the Fossa
valis and Surrounding Structures
he intact atrial septum is formed from fusion of the
eptum primum and the septum secundum. Both septae
xtend from the roof of the atria toward the endocardial
ushions. The septum primum, which is the LA septum, is
bsorbed superiorly, leaving the septum secundum, or the
A septum, to cover this superior defect (ostium secundum)
nd separate the atria. The area of fusion of the muscular,
eptum secundum and the thin portion of the septum
rimum is known as the limbus (10). The limbus is most
ronounced superiorly and laterally, and forms the raised
argin around the fossa ovalis (Fig. 1). Thus, the fossa
valis appears as a depression in the interatrial septum when
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June 3, 2008:2116–22 Emerging Applications for TS Catheterizationhin fibrous tissue (10,11). Surrounding the fossa is the
uscular septum, the thick portions of the septum secun-
um and primum composed primarily of atrial muscle. The
ossa ovalis is either oval or circular with an average area of
.5 to 2.4 cm2 in the adult (11). It is located posteriorly, at
he junction of the mid and lower third of the RA. In
atients with dilated aortae and in those with mitral valve
isease and a bulging LA, the fossa ovalis can be located
ore superiorly or inferiorly, respectively.
ocalization of the Fossa Ovalis
ocalization of the fossa ovalis for TS puncture has tradi-
ionally been done by fluoroscopic imaging. A pigtail
atheter is placed retrograde into the aortic root so that its
ip marks the location of the aortic valve. The cardiac
ilhouette identifies the posterior and lateral borders of the
tria (12). Several different angiographic projections are
sed to puncture the septum safely. In the anteroposterior
rojection, the fossa lies below the pigtail catheter in the
id RA silhouette (Fig. 2A). In the lateral projection,
he fossa is usually halfway along the imaginary line from
he pigtail catheter tip to the posterior border of the heart
Fig. 2B). In the right anterior oblique projection (40° to
0°), the outline of the atrial septum is en face. The fossa is
osterior and 1 to 3 cm inferior to the pigtail catheter tip,
ut anterior to the RA silhouette (Fig. 2B). In difficult cases,
n RA angiogram with delayed LA angiography can help
isualize the septum (overlap area). “Tattooing” of the
eptum with a 1-ml contrast injection through the TS
uncture needle can also help visualize the septum.
Echocardiographic visualization of the atrial septum has
ided in the safety of TS catheterization (13). Transthoracic
chocardiography (TTE) has limited utility, but transesoph-
Figure 1 Gross Examination of the FO From the Right Atrium
Right atrial view of the atrial septum with limbic ledge seen superiorly (below
dotted line) and depressed fossa ovalis (FO) inferiorly. SVC  superior vena cava.ggeal echocardiography (TEE) is
ore useful, particularly when
isualizing a specific area of the
ossa ovalis to be punctured. Su-
erior/inferior localization is
een best in the bicaval view
90°), and anterior/posterior lo-
alization is seen best in the
-chamber view (0°). Tenting
Fig. 3A) of the fossa ovalis (the
hin septum) by the TS catheter
ip indicates correct positioning,
ven if the needle or catheter
annot be visualized. Newer im-
ging modalities such as intracar-
iac echocardiography (AcuNav
CE, Siemens Medical Systems,
ountain View, California)
12,14,15) have also been used with success. The role of
-dimensional TEE has yet to be fully evaluated, although
nitial experience is positive (Fig. 3B). CardioOptics (Boul-
er, Colorado) manufactures a catheter that emits infrared
ight and can image through flowing blood in real time.
his catheter may be useful in TS catheterization, allowing
irect visualization of the fossa ovalis. Animal testing has
een completed, and Phase I human trials are pending.
uncture of the Fossa Ovalis
uncture of the fossa ovalis begins with insertion of the
eedle delivery catheter and dilator to the level of the
uperior vena cava from the right common femoral vein.
he catheter has a 270° curve at the end that is straightened
y the dilator, and is most commonly a Mullins TS
ntroducer (Medtronic, Minneapolis, Minnesota). The ra-
ius of the end of the catheter is available in different sizes,
llowing variable reach within the RA. The needle is then
nserted into the dilator, and allowed to freely rotate as it is
dvanced. Passage of the needle is easier if the sheath and
ilator is introduced from the right rather than left femoral
ein because of tortuosity. Fluoroscopy is used to visualize
he needle as it is advanced up to the tip of the dilator so as
o avoid inadvertent passage out of the dilator and sheath.
The needle most commonly used is a Brockenbrough
eedle (Medtronic). This needle is an 18-gauge hollow tube
hat tapers distally to 21 gauge. The proximal end has a
ange with an arrow that points to the position of the
eedle tip. With the needle tip just within the dilator, the
ntire assembly is rotated such that the needle points to a 4
’clock orientation (ceiling of the room is 12 o’clock
rientation, floor is 6 o’clock orientation) and withdrawn
nto the mid RA. Using the fluoroscopic projections as
reviously described, the dilator is then advanced to catch
he limbus of the fossa ovalis. In the minority of patients in
hom the limbus is not prominent, echocardiographic
Abbreviations
and Acronyms
ASD  atrial septal defect
EP  electrophysiology
LA  left atrial/atrium
PFO  patent foramen
ovale
PVL  paravalvular leak
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Emerging Applications for TS Catheterization June 3, 2008:2116–22ly are advanced as a unit, tenting the fossa. The needle is
hen rotated to 3 o’clock to prevent posterior puncture and
s fully advanced. Puncture into the LA can be confirmed by
ressure transduction through the needle (Fig. 4), aspiration
f oxygenated blood, and injection of contrast.
In 20% to 25% of adult patients, the fossa ovalis is probe
atent (patent foramen ovale [PFO]) and may not require
eedle puncture (10,11). In approximately two-thirds of
atients, the fossa is paper thin, and the catheter can be
assed into the LA with gentle pressure and rotation of the
ilator (10). Puncture is associated with a tactile feeling of
he septum giving way. The dilator and sheath are then
dvanced over the needle (without advancing the needle) to
void injury to the posterior LA wall. Some operators
ntroduce a 0.014-inch angioplasty wire through the needle
Figure 2 Fluoroscopic Views During Transseptal Puncture
(A) Transseptal puncture performed in the anteroposterior projection with fluorosc
the transseptal dilator engages the fossa ovalis inferiorly and medially to the aorti
transseptal dilator engages the fossa ovalis in the lower third of the imaginary line
of the left atrium (heavy dashed line). (C) Transseptal puncture performed in the
engages the fossa ovalis posterior to the pigtail catheter (aortic valve) but anterior
Figure 3 2- and 3-Dimensional Echocardiographic Views During
(A) 2-dimensional transesophageal echocardiographic imaging depicts tenting (arr
(B) 3-dimensional transesophageal echocardiographic imaging visualizes tenting (nto the LA and pulmonary vein to prevent inadvertent
uncture of the LA free wall by the needle or dilator (16).
ortunately, serious morbidity or mortality after needle
uncture of the LA free wall or aorta is uncommon if the
heath and dilator are not advanced. Overall, serious com-
lications from TS catheterization are1% (1,17,18). After
uccessful puncture of the atrial septum, the patient should
e immediately anticoagulated (heparin or direct thrombin
ntagonist) to minimize the risk of thromboembolism.
ewer Methods for Atrial Septal Puncture
n an attempt to improve the TS technique, a new system
hat uses radiofrequency (RF) energy to puncture the
eptum (Radiofrequency Transseptal System, Baylis Medi-
aging. The pigtail catheter marks the location of the aortic valve, and the tip of
. (B) Transseptal puncture performed in the lateral fluoroscopic projection. The
dashed line) connecting the pigtail catheter (aortic valve) and the posterior wall
nterior oblique projection with fluoroscopic imaging. The transseptal dilator (TC)
ht atrial silhouette (dashed line).
sseptal Puncture
the atrial septum into the left atrium (LA).
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June 3, 2008:2116–22 Emerging Applications for TS Catheterizational, Montreal, Canada) has been developed (19). Instead of
needle, an RF catheter is introduced into the dilator/
heath assembly (Fig. 5A). This catheter delivers 5 W
nergy for 2 to 5 s and can perforate the atrial septum after
to 4 pulses. It has been used in 5 patients undergoing
alloon mitral valvuloplasty and was successful in 4. This
echnology may have an advantage in thick, scarred, calci-
ed, or patched atrial septa, where excess force could result
n unsuccessful puncture or in perforation of the LA free
all secondary to catheter momentum.
Another new technology that also may improve the safety
f TS puncture is the excimer laser catheter (0.9-mm
lirpath X-80, Spectranetics, Colorado Springs, Colorado)
20–22). The laser catheter is inserted via a modified
ullins sheath and dilator (inner lumen compatible with a
.038-inch wire) and can puncture the septum after a brief
Figure 4 Pressure Tracing From Transseptal Needle During Tra
Right atrial (RA) pressure wave form becomes blunted (BP) as the needle engages
septum. After the needle passes through the septum, a left atrial (LA) pressure wa
Figure 5 New Transseptal Catheterization Techniques Using a
(A) A radiofrequency catheter is inserted into dilator and sheath and ablates a thi
septal System, Baylis Medical, Montreal, Quebec, Canada). (B) The LA-Crosse sys
cross the atrial septum from the right internal jugular vein (courtesy of St. Jude M2 to 5 s) application of laser energy. The laser catheter
equires less force (10-fold) to cross the septum compared
ith the Brockenbrough needle, and can then be used as a
ail over which the Mullins sheath and dilator can be
dvanced. Currently, only data from animal studies are
vailable, although the technology seems promising and can
e used “off the shelf” with existing deflectable guiding
atheters (Morph catheter, Biocardia, San Francisco, Cali-
ornia, and Naviport catheter, Cardima, Fremont, California).
In cases in which TS catheterization cannot be performed
rom the femoral vein, a new system has been developed for
afe puncture of the LA from the internal jugular vein. The
A-Crosse system (St. Jude Medical, St. Paul, Minnesota)
s composed of 3 parts: a stabilizer sheath, a guide catheter,
nd a flexible puncture screw (Fig. 5B). The stabilizer
heath is placed from the right internal jugular vein such
tal Catheterization
m is seen.
frequency Catheter or an Internal Jugular Vein Approach
atrial septum to cross into the left atrium (courtesy of Radiofrequency Trans-
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Emerging Applications for TS Catheterization June 3, 2008:2116–22hat the distal end lies in the inferior vena cava and the side
pening faces the mid RA. A guide catheter is advanced
hrough the stabilizer sheath and out the side opening until
ts distal end is in contact with the fossa ovalis. The flexible
uncture screw is then advanced through the guide catheter
o its tip. When it contacts the atrial septum, the puncture
crew is rotated and penetrates the atrial septum. Once LA
ressure is measured through the end hole of the puncture
crew, an Inoue guidewire is advanced into the LA. This
ystem has been 100% successful in animal models guided
y fluoroscopy, and can be used to perform multiple
unctures in selective portions of the atrial septum. Addi-
ionally, introduction of catheters from the internal jugular
ein through the superior vena cava and across the atrial
eptum may offer a more favorable trajectory than the
emoral approach for transcatheter interventions on the
itral valve. Human evaluation is pending.
merging Indications for TS Puncture
S catheterization in electrophysiology (EP). The car-
iac subspecialty of EP accounts for the single most com-
on context in which TS punctures are performed in the
.S. Interest in the refinement and perfection of the TS
echnique has paralleled the dramatic increase in the num-
er of ablative procedures performed for atrial fibrillation in
he last 5 years (9,23). In addition to RF ablation for atrial
brillation, TS puncture is routine for ablation of accessory
athways located along the mitral annular region, LA
achycardias and flutters, and less commonly for variants of
trioventricular nodal reentrant tachycardia. The TS route
lso provides a useful alternative to the retroaortic approach
or ablation within the left ventricle and left ventricular
utflow tract.
In most centers, TS puncture is performed under fluoro-
copic biplanar guidance using methods described above.
dditionally, a diagnostic catheter in the coronary sinus aids
n the localization of the fossa ovalis. Often, EP procedures
equire 2 or more sheaths across the fossa ovalis. This can be
ccomplished by 2 separate TS punctures or a single pass
ith the Brockenbrough needle. In the latter case, the initial
heath, which is already across the atrial septum, can be
ithdrawn into the RA over a guidewire in the LA. A
econd sheath or ablation catheter can then pass through the
reviously created rent in the septum. The initial sheath is
hen reinserted over the guidewire. On occasion, patients
equire repeat TS procedures for atrial fibrillation ablation
24). If previous punctures have been performed, the fossa
valis can become thickened and fibrotic. This can obscure
he physical landmarks, prevent the characteristic leftward
ovement of the TS needle into the fossa, and require
ignificant forward pressure for puncture with the needle. In
his situation and in the case of prior aortic root surgery
djuncts to fluoroscopic visualization, such as intracardiac or
EE, are most useful. sFO and atrial septal defect (ASD) repair. The second
ost common use for TS catheterization is percutaneous
epair of ASD and PFO. Percutaneous ASD repair is a
alidated alternative to surgical repair (25), and is used
rimarily to prevent or reverse the untoward consequences
f left-to-right shunting across the atrial septum (pulmo-
ary hypertension, right ventricular failure). Alternatively,
ercutaneous PFO closure has been used to prevent the
roblems of right-to-left shunting, specifically secondary
troke prevention. Ongoing trials are also evaluating the role
f PFO closure in migraine reduction.
In the majority of cases, the ASD and PFO can be
rossed with the use of a multipurpose catheter and a J-wire
ithout the need for TS puncture. In rare occasions, atrial
eptal aneurysms may “pocket” the catheter tip and wire,
reventing the cannulation of a small ASD or PFO. In this
ituation and in the long-tunnel variant PFO, TS puncture
as been used to place a catheter in the LA, and deploy a
losure device to seal the defect (26,27). This technique
equires echocardiographic guidance to puncture the septum
s close to the defect as possible.
ercutaneous mitral valve repair. Percutaneous mitral
alve repair strategies include leaflet repair, coronary sinus
nnuloplasty, and noncoronary sinus annuloplasty with or
ithout myocardial reduction (6,7,28,29). The largest ex-
erience with repair strategies has been with percutaneous
eaflet clipping in the treatment of primary mitral regurgi-
ation. The MitraClip device (Evalve Inc., Menlo Park,
alifornia), requires the introduction of a 22-F device via
S puncture (8). The TS puncture should be performed
nder ultrasound guidance in order to pierce the septum
uperiorly and posteriorly. This high TS puncture allows
dequate distance above the mitral valve plane for manipu-
ation of the guiding and delivery catheter and to properly
lace the mitral valve clip.
The Ample PS3 System (Ample Medical, Foster City,
alifornia) also involves TS puncture. A T-bar implant is
elivered to the posterior annulus via the coronary sinus. A
S puncture is performed to tether the T-bar to an
mplatzer (AGA Medical, Minneapolis, Minnesota) device
nchored in the atrial septum.
A appendage closure. The LA appendage is positioned in
he anterior-superior portion of the LA, above the mitral valve.
he Watchman device (Atritech Company, Plymouth, Min-
esota) is a nitinol cage with a polyethylene membrane that can
e implanted into the LA appendage of patients with atrial
brillation to prevent stroke (30). For placement of this device,
S puncture is performed in the superior fossa ovalis so that
he delivery sheath is coaxial with the LA appendage, and
evice deployment is facilitated.
ercutaneous left ventricular assist device. The Tandem-
eart Device (CardiacAssist, Pittsburgh, Pennsylvania) is a
irculatory assist device (31–33) that retrogradely perfuses
he aorta with oxygenated blood from the LA. After TS
uncture, a 21-F cannula is advanced across the atrial
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June 3, 2008:2116–22 Emerging Applications for TS Catheterizationenous cannula (inflow) is connected to a 15- to 18-F
annula in the iliac artery (outflow) via a rotary pump. The
ow can be as high as 4.0 l/min and requires appropriate
lacement of the distal end of the LA cannula in the
id-posterior LA. Ultrasound guidance for placement of
he LA catheter is recommended.
aravalvular leak (PVL) closure. Paravalvular leak of mi-
ral prostheses can be repaired percutaneously from a TS
pproach (34), particularly if the leak is along the lateral
spect of the LA. The TS puncture should be in the middle
r inferior fossa ovalis to direct a right Judkins catheter to
he lateral wall of the atrium at the level of the mitral valve.
PVL along the medial aspect of mitral prostheses is
echnically more difficult to repair because the acute angle
eeded to access the PVL. Such leaks might be approached
rom a TS puncture performed from the right internal
ugular in the future. A TS puncture has also been per-
ormed to snare a wire from the left ventricle or LA when
losing an aortic or mitral PVL.
ther procedures. The TS technique has been used in a
ariety of other procedures, including pulmonary vein ste-
osis intervention, antegrade VSD closure, stent implanta-
ion in the right internal carotid artery (35), and atrial
eptostomy. Indications for TS catheterization will increase
s more interventions are performed for treatment of struc-
ural heart disease.
onclusions
lthough once popular, TS catheterization has been shelved
y all except electrophysiologists and a few interventionalists
ntil recently. Today’s invasive cardiologists will have to
efamiliarize themselves with the technique as well as
ecome involved with the newer TS devices and more
dvanced imaging. Training will remain an issue because of
he number of cases and the lack of recent experience.
herefore, simulators and echocardiographic imaging
hould prove helpful. In the current era of catheter therapies
or structural heart disease and EP, we will certainly see new
nd a resurgence of old techniques to aid in the success of
orthcoming procedures.
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